Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 9

recruiting
3 973
countries
28
conditions
2 104

464 trials match your criteria

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Upadacitinib

Study of Datopotamab Deruxtecan for Patients with Triple-Negative Breast Cancer and New or Worsening Brain Metastases

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Datopotamab Deruxtecan

Study of Aficamten for Children with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Aficamten

Endometrial cancer+13

Recruiting

Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Ifinatamab Deruxtecan

Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years
  • Substances:Nipocalimab

Study on the Safety and Effectiveness of BEAM-302 with MR0005 and GR0015 for Adults with Alpha-1 Antitrypsin Deficiency-Related Lung or Liver Disease

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years
  • Substances:GR0015

Study of Sarilumab for Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA)

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Sarilumab

Study of Opevesostat, Olaparib, and Cabazitaxel in Patients with Advanced Prostate Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel

Study of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin

Study on Preventing Bleeding in Children with Severe von Willebrand Disease Using Vonicog Alfa and Octocog Alfa

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Octocog Alfa

Study on Early Treatment of Patent Ductus Arteriosus with Paracetamol in Extremely Low Birth Weight Infants

Registered drug
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Paracetamol
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Paclitaxel
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.